Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Leist

Showing results (271-280 of 310) with videos related to

Pageof 31
Sort By:
ALTEX|August 25, 2016
Good Cell Culture Practice for stem cells and stem-cell-derived modelsDavid Pamies, Anna Bal-Price, Anton Simeonov, et al.
ALTEX|July 17, 2014
State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiologyNatalie Alépée, Anthony Bahinski, Mardas Daneshian, et al.
Toxicology and Applied Pharmacology|February 16, 2018
Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposesEllen Fritsche, Philippe Grandjean, Kevin M Crofton, et al.
ALTEX|October 16, 2025
An Alternative Safety Profiling Algorithm (ASPA) to transform next generation risk assessment into a structured and transparent processMarcel Leist, Silvia Tangianu, Femke Affourtit, et al.
Archives of Toxicology|January 26, 2015
International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposesAnna Bal-Price, Kevin M Crofton, Marcel Leist, et al.
ALTEX|January 18, 2025
Mapping out strategies to further develop human-relevant, new approach methodology (NAM)-based developmental neurotoxicity (DNT) testingEike Cöllen, Kristina Bartmann, Jonathan Blum, et al.
Science (New York, N.Y.)|July 13, 2004
Derivatives of erythropoietin that are tissue protective but not erythropoieticMarcel Leist, Pietro Ghezzi, Giovanni Grasso, et al.
ALTEX|May 14, 2013
Metabolomics in toxicology and preclinical researchTzutzuy Ramirez, Mardas Daneshian, Hennicke Kamp, et al.
ALTEX|December 4, 2023
Protectiveness of NAM-based hazard assessment - which testing scope is required?Walter Zobl, Annette Bitsch, Jonathan Blum, et al.
ALTEX|November 5, 2015
Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicologySarah Gordon, Mardas Daneshian, Joke Bouwstra, et al.
Pageof 31

Showing results (271-280 of 310) with videos related to

Sort By:
Pageof 31
ALTEX|August 25, 2016
Good Cell Culture Practice for stem cells and stem-cell-derived modelsDavid Pamies, Anna Bal-Price, Anton Simeonov, et al.
ALTEX|July 17, 2014
State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiologyNatalie Alépée, Anthony Bahinski, Mardas Daneshian, et al.
Toxicology and Applied Pharmacology|February 16, 2018
Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposesEllen Fritsche, Philippe Grandjean, Kevin M Crofton, et al.
ALTEX|October 16, 2025
An Alternative Safety Profiling Algorithm (ASPA) to transform next generation risk assessment into a structured and transparent processMarcel Leist, Silvia Tangianu, Femke Affourtit, et al.
Archives of Toxicology|January 26, 2015
International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposesAnna Bal-Price, Kevin M Crofton, Marcel Leist, et al.
ALTEX|January 18, 2025
Mapping out strategies to further develop human-relevant, new approach methodology (NAM)-based developmental neurotoxicity (DNT) testingEike Cöllen, Kristina Bartmann, Jonathan Blum, et al.
Science (New York, N.Y.)|July 13, 2004
Derivatives of erythropoietin that are tissue protective but not erythropoieticMarcel Leist, Pietro Ghezzi, Giovanni Grasso, et al.
ALTEX|May 14, 2013
Metabolomics in toxicology and preclinical researchTzutzuy Ramirez, Mardas Daneshian, Hennicke Kamp, et al.
ALTEX|December 4, 2023
Protectiveness of NAM-based hazard assessment - which testing scope is required?Walter Zobl, Annette Bitsch, Jonathan Blum, et al.
ALTEX|November 5, 2015
Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicologySarah Gordon, Mardas Daneshian, Joke Bouwstra, et al.
Pageof 31